RBC Capital Starts Infinity Pharmaceutical (INFI) at Outperform
Tweet Send to a FriendGet Alerts INFI Hot Sheet
Price: $24.32 +5.19%
Rating Summary:
9 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 23 | New: 29
Rating Summary:
9 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 23 | New: 29
Trade INFI Now!
RBC Capital initiates coverage on Infinity Pharmaceutical (NASDAQ: INFI) with a Outperform. PT $28.00.
For an analyst ratings summary and ratings history on Infinity Pharmaceutical click here. For more ratings news on Infinity Pharmaceutical click here.
Shares of Infinity Pharmaceutical closed at $23.45 yesterday, with a 52 week range of $5.50-$27.29.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on Infinity Pharmaceutical click here. For more ratings news on Infinity Pharmaceutical click here.
Shares of Infinity Pharmaceutical closed at $23.45 yesterday, with a 52 week range of $5.50-$27.29.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Topeka Capital Starts RDA Microelectronics (RDA) at Buy
- Topeka Capital Starts InvenSense (INVN) at Buy
- Topeka Capital Starts Atmel (ATML) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
RBC Capital
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
